mutagenesis

Molnupiravir, a SARS-CoV-2 antiviral drug, is mutagenic in cells

7 Comments / Basic virology / By

Molnupiravir might be the first highly effective antiviral drug given emergency use authorization for treatment of COVID-19. Should we be concerned about the results of a recent study which show that the drug is mutagenic in cells? Molnupiravir is an orally available pro-drug of the nucleoside analog N4-hydroxycytidine (NHC). The latter is a nucleoside analogue …

Molnupiravir, a SARS-CoV-2 antiviral drug, is mutagenic in cells Read More »

TWiV 514: Staying below the ADAR

4 Comments / This Week in Virology / By

The TWiVumvirate reviews this years crop of Nobel Prizes, and how cells prevent leakage of mitochondrial double-stranded RNA into the cytoplasm, which would otherwise lead to the production of interferon. <span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”></span>&lt;span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”&gt;&lt;/span&gt;&amp;lt;span data-mce-type=”bookmark” style=”display: inline-block; width: …

TWiV 514: Staying below the ADAR Read More »

Scroll to Top